Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Medy-Tox60 enrolled

Overview

The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Cervical Dystonia

Interventions

MT10109BIOLOGICAL

Botulinum toxin type A

BOTOX(Registered trade mark)BIOLOGICAL

Botulinum toxin type A

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female aged 18\~75 * Have no clinically significant medical condition * Cervical dystonia Exclusion Criteria: * Pregnant or lactation * Subjects who have been administered the following drugs within the previous 1 month

Locations (1)

Unnamed facility

Brisbane, Australia

Outcomes

Primary Outcomes

Number of adverse events

Time frame: Day 30

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.